H-1B sponsorship profile: Prime Therapeutics LLC. Across U.S. Department of Labor LCA disclosures, Prime Therapeutics LLC filed 41 Labor Condition Applications covering 41 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (41 certified of 41 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Prime Therapeutics LLC’s H-1B petitions range from $114,565 at the low end to $173,276 at the high end, with a petition-weighted average of $140,384. That range reflects the mix of occupations the company sponsors, led by Lead Software Engineer (4 petitions at $128,526 avg), followed by IT Software Engineer Sr and Systems Developer Principal IT. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Prime Therapeutics LLC is headquartered in Eagan, MN under NAICS code 54169, and places H-1B workers across 6 states, most heavily in MN, TX, VA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Prime Therapeutics LLC ranks. By H-1B petition volume, Prime Therapeutics LLC is #5,603 of 119,880 employers nationally and #62 of 1,538 employers headquartered in MN. Both ranks are computed live from the same underlying petition counts, not a separate estimate.